{"id":57745,"date":"2026-02-24T18:12:38","date_gmt":"2026-02-24T10:12:38","guid":{"rendered":"https:\/\/flcube.com\/?p=57745"},"modified":"2026-02-24T18:12:39","modified_gmt":"2026-02-24T10:12:39","slug":"jj-invests-1b-in-pennsylvania-cell-therapy-facility-expands-manufacturing-for-cancer-and-neurology-pipeline","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=57745","title":{"rendered":"J&amp;J Invests $1B+ in Pennsylvania Cell Therapy Facility \u2013 Expands Manufacturing for Cancer and Neurology Pipeline"},"content":{"rendered":"\n<p><strong>Johnson &amp; Johnson (J&amp;J, <a href=\"https:\/\/www.google.com\/finance\/quote\/JNJ:NYSE\">NYSE:\u202fJNJ<\/a>)<\/strong> announced a <strong>more than USD\u202f1\u202fbillion investment<\/strong> to build a <strong>next\u2011generation cell therapy manufacturing facility<\/strong> in <strong>Montgomery County, Pennsylvania<\/strong>. The facility will significantly expand the company&#8217;s <strong>U.S. manufacturing capacity<\/strong> to support its industry\u2011leading portfolio and pipeline of <strong>transformational medicines<\/strong> targeting cancer, immune\u2011mediated diseases, and neurological conditions.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-investment-overview\">Investment Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>Johnson &amp; Johnson (NYSE:\u202fJNJ)<\/td><\/tr><tr><td><strong>Investment Amount<\/strong><\/td><td><strong>&gt;\u202fUSD\u202f1\u202fbillion<\/strong><\/td><\/tr><tr><td><strong>Facility Type<\/strong><\/td><td>Next\u2011generation cell therapy manufacturing plant<\/td><\/tr><tr><td><strong>Location<\/strong><\/td><td>Montgomery County, Pennsylvania<\/td><\/tr><tr><td><strong>Strategic Context<\/strong><\/td><td>Part of USD\u202f55\u202fbillion U.S. investment through early 2029<\/td><\/tr><tr><td><strong>Therapeutic Focus<\/strong><\/td><td>Cancer, immune\u2011mediated diseases, neurological diseases<\/td><\/tr><tr><td><strong>Job Creation<\/strong><\/td><td><strong>&gt;\u202f500<\/strong> skilled biomanufacturing jobs (operational); <strong>&gt;\u202f4,000<\/strong> construction jobs (development)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale\">Strategic Rationale<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Cell Therapy Scale\u2011Up:<\/strong> The investment addresses the <strong>manufacturing bottleneck<\/strong> constraining cell therapy commercialization, enabling J&amp;J to meet growing demand for personalized cellular medicines.<\/li>\n\n\n\n<li><strong>Pipeline Support:<\/strong> The facility will produce therapies for J&amp;J&#8217;s expanding <strong>oncology, immunology, and neuroscience portfolios<\/strong>, including CAR\u2011T and other cell\u2011based modalities in late\u2011stage development.<\/li>\n\n\n\n<li><strong>U.S. Manufacturing Commitment:<\/strong> The announcement reinforces J&amp;J&#8217;s <strong>USD\u202f55\u202fbillion U.S. investment pledge<\/strong>, demonstrating long\u2011term commitment to domestic biopharma infrastructure and supply chain resilience.<\/li>\n\n\n\n<li><strong>Workforce Development:<\/strong> Creation of <strong>500+ high\u2011skilled biomanufacturing positions<\/strong> addresses talent demand in the Philadelphia region&#8217;s growing life sciences corridor.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-context\">Market Context<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Cell Therapy Market Growth:<\/strong> The global cell therapy market is projected to exceed <strong>$50\u202fbillion<\/strong> by 2030, driven by approvals in hematologic cancers and emerging solid tumor applications.<\/li>\n\n\n\n<li><strong>Manufacturing Differentiation:<\/strong> <strong>Next\u2011generation facilities<\/strong> incorporating automation and closed\u2011system processing are critical competitive advantages for reducing cost\u2011of\u2011goods and improving patient access.<\/li>\n\n\n\n<li><strong>Regional Ecosystem:<\/strong> Montgomery County&#8217;s proximity to <strong>Philadelphia&#8217;s cell and gene therapy cluster<\/strong>\u2014including the University of Pennsylvania&#8217;s pioneering research\u2014positions J&amp;J to leverage local talent and innovation partnerships.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-economic-impact\">Economic Impact<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Category<\/th><th>Impact<\/th><\/tr><\/thead><tbody><tr><td><strong>Construction Phase<\/strong><\/td><td>&gt;\u202f4,000 jobs during site development<\/td><\/tr><tr><td><strong>Operational Phase<\/strong><\/td><td>&gt;\u202f500 skilled biomanufacturing positions<\/td><\/tr><tr><td><strong>Supply Chain<\/strong><\/td><td>Secondary economic benefits for regional vendors and service providers<\/td><\/tr><tr><td><strong>Tax Revenue<\/strong><\/td><td>Significant local and state contributions upon operationalization<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding facility construction timelines, operational capacity, and pipeline commercialization. Actual results may differ due to risks including construction delays, regulatory approvals, and technology transfer challenges.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Johnson &amp; Johnson (J&amp;J, NYSE:\u202fJNJ) announced a more than USD\u202f1\u202fbillion investment to build a next\u2011generation&#8230;<\/p>\n","protected":false},"author":1,"featured_media":57808,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[150,149,858],"class_list":["post-57745","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","tag-jj","tag-johnson-johnson","tag-nyse-jnj"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>J&amp;J Invests $1B+ in Pennsylvania Cell Therapy Facility \u2013 Expands Manufacturing for Cancer and Neurology Pipeline - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Johnson &amp; Johnson (J&amp;J, NYSE:\u202fJNJ) announced a more than USD\u202f1\u202fbillion investment to build a next\u2011generation cell therapy manufacturing facility in Montgomery County, Pennsylvania. The facility will significantly expand the company&#039;s U.S. manufacturing capacity to support its industry\u2011leading portfolio and pipeline of transformational medicines targeting cancer, immune\u2011mediated diseases, and neurological conditions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=57745\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"J&amp;J Invests $1B+ in Pennsylvania Cell Therapy Facility \u2013 Expands Manufacturing for Cancer and Neurology Pipeline\" \/>\n<meta property=\"og:description\" content=\"Johnson &amp; Johnson (J&amp;J, NYSE:\u202fJNJ) announced a more than USD\u202f1\u202fbillion investment to build a next\u2011generation cell therapy manufacturing facility in Montgomery County, Pennsylvania. The facility will significantly expand the company&#039;s U.S. manufacturing capacity to support its industry\u2011leading portfolio and pipeline of transformational medicines targeting cancer, immune\u2011mediated diseases, and neurological conditions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=57745\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-24T10:12:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-24T10:12:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2406.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57745#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57745\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"J&amp;J Invests $1B+ in Pennsylvania Cell Therapy Facility \u2013 Expands Manufacturing for Cancer and Neurology Pipeline\",\"datePublished\":\"2026-02-24T10:12:38+00:00\",\"dateModified\":\"2026-02-24T10:12:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57745\"},\"wordCount\":400,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57745#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/2406.webp\",\"keywords\":[\"J&amp;J\",\"Johnson &amp; Johnson\",\"NYSE: JNJ\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=57745#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57745\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=57745\",\"name\":\"J&amp;J Invests $1B+ in Pennsylvania Cell Therapy Facility \u2013 Expands Manufacturing for Cancer and Neurology Pipeline - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57745#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57745#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/2406.webp\",\"datePublished\":\"2026-02-24T10:12:38+00:00\",\"dateModified\":\"2026-02-24T10:12:39+00:00\",\"description\":\"Johnson & Johnson (J&J, NYSE:\u202fJNJ) announced a more than USD\u202f1\u202fbillion investment to build a next\u2011generation cell therapy manufacturing facility in Montgomery County, Pennsylvania. The facility will significantly expand the company's U.S. manufacturing capacity to support its industry\u2011leading portfolio and pipeline of transformational medicines targeting cancer, immune\u2011mediated diseases, and neurological conditions.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57745#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=57745\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57745#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/2406.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/2406.webp\",\"width\":1080,\"height\":608,\"caption\":\"J&J Invests $1B+ in Pennsylvania Cell Therapy Facility \u2013 Expands Manufacturing for Cancer and Neurology Pipeline\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57745#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"J&amp;J Invests $1B+ in Pennsylvania Cell Therapy Facility \u2013 Expands Manufacturing for Cancer and Neurology Pipeline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"J&amp;J Invests $1B+ in Pennsylvania Cell Therapy Facility \u2013 Expands Manufacturing for Cancer and Neurology Pipeline - Insight, China&#039;s Pharmaceutical Industry","description":"Johnson & Johnson (J&J, NYSE:\u202fJNJ) announced a more than USD\u202f1\u202fbillion investment to build a next\u2011generation cell therapy manufacturing facility in Montgomery County, Pennsylvania. The facility will significantly expand the company's U.S. manufacturing capacity to support its industry\u2011leading portfolio and pipeline of transformational medicines targeting cancer, immune\u2011mediated diseases, and neurological conditions.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=57745","og_locale":"en_US","og_type":"article","og_title":"J&amp;J Invests $1B+ in Pennsylvania Cell Therapy Facility \u2013 Expands Manufacturing for Cancer and Neurology Pipeline","og_description":"Johnson & Johnson (J&J, NYSE:\u202fJNJ) announced a more than USD\u202f1\u202fbillion investment to build a next\u2011generation cell therapy manufacturing facility in Montgomery County, Pennsylvania. The facility will significantly expand the company's U.S. manufacturing capacity to support its industry\u2011leading portfolio and pipeline of transformational medicines targeting cancer, immune\u2011mediated diseases, and neurological conditions.","og_url":"https:\/\/flcube.com\/?p=57745","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-02-24T10:12:38+00:00","article_modified_time":"2026-02-24T10:12:39+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2406.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=57745#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=57745"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"J&amp;J Invests $1B+ in Pennsylvania Cell Therapy Facility \u2013 Expands Manufacturing for Cancer and Neurology Pipeline","datePublished":"2026-02-24T10:12:38+00:00","dateModified":"2026-02-24T10:12:39+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=57745"},"wordCount":400,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=57745#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2406.webp","keywords":["J&amp;J","Johnson &amp; Johnson","NYSE: JNJ"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=57745#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=57745","url":"https:\/\/flcube.com\/?p=57745","name":"J&amp;J Invests $1B+ in Pennsylvania Cell Therapy Facility \u2013 Expands Manufacturing for Cancer and Neurology Pipeline - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=57745#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=57745#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2406.webp","datePublished":"2026-02-24T10:12:38+00:00","dateModified":"2026-02-24T10:12:39+00:00","description":"Johnson & Johnson (J&J, NYSE:\u202fJNJ) announced a more than USD\u202f1\u202fbillion investment to build a next\u2011generation cell therapy manufacturing facility in Montgomery County, Pennsylvania. The facility will significantly expand the company's U.S. manufacturing capacity to support its industry\u2011leading portfolio and pipeline of transformational medicines targeting cancer, immune\u2011mediated diseases, and neurological conditions.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=57745#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=57745"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=57745#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2406.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2406.webp","width":1080,"height":608,"caption":"J&J Invests $1B+ in Pennsylvania Cell Therapy Facility \u2013 Expands Manufacturing for Cancer and Neurology Pipeline"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=57745#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"J&amp;J Invests $1B+ in Pennsylvania Cell Therapy Facility \u2013 Expands Manufacturing for Cancer and Neurology Pipeline"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2406.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/57745","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=57745"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/57745\/revisions"}],"predecessor-version":[{"id":57818,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/57745\/revisions\/57818"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/57808"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=57745"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=57745"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=57745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}